Growth factors and the gastrointestinal tract

Nutrition

Volumn 14, Issue 10, 1998, Pages 771-774

  Murphy, M Stephen ^a  

^a Institute of Child Health   (United Kingdom)

Author keywords

Adaptation epidermal growth factor; Growth factors; Hepatocyte growth factor; Transforming growth factor ; Trefoil peptides

Indexed keywords

AMPHIREGULIN; BETACELLULIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TREFOIL PEPTIDE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; GASTROINTESTINAL TRACT; HUMAN; INTESTINE ADAPTATION; INTESTINE CELL; INTESTINE MUCOSA; INTESTINE VILLUS; MILK; NUTRIENT; ORGANOGENESIS; PRIORITY JOURNAL; ULCER HEALING;

EID: 0032188840     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(98)00081-1     Document Type: Conference Paper

References (33)

1. Cross M., Dexter M.T. Growth factors in development, transformation, and tumorigenesis. Cell. 64:1991;271.
2. Uribe J.M., Barrett K.E. Nonmitogenic actions of growth factors an integrated view of their role in intestinal physiology and pathophysiology . Gastroenterology. 112:1997;255.
3. Barnard J.A., Beauchamp R.D., Russell W.E., Dubois R.N., Coffey R.J. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology. 108:1995;564.
4. Marti U., Burwen S.J., Jones A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver an update . Hepatology. 9:1989;126.
5. Whitman M., Melton D.A. Growth factors in early embryogenesis. Ann Rev Cell Biol. 5:1989;93.
6. Lemoine N.R., Leung H.Y., Gullick W.J. Growth factors in the gastrointestinal tract. Gut. 33:1992;1297.
7. Playford R.J. Peptides and gastrointestinal mucosal integrity. Gut. 37:1995;595.
8. Playford R.J., Wright N.A. Why is epidermal growth factor present in the gut lumen? Gut. 38:1996;303.
9. Wright N.A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:1990;82.
10. Koyama S., Podalsky D.K. Differential expression of transforming growth factors a and b in rat intestinal epithelial cells. J Clin Invest. 83:1989;1768.
11. Jhappan C., Stahle C., Harkins R.N., Fausto N., Smith G.H., Merlino G.T. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 61:1990;1137.
12. Sandgren E.P., Luetteke N.C., Plamiter R.D., Brinster R.L., Lee D.C. Overexpression of TGFα in transgenic mice induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast . Cell. 61:1990;1121.
13. Miettinen P.J., Berger J.E., Meneses J., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337.
14. Threadgill D.W., Dlugosz A.A., Hansen L.A., et al. Targeted disruption of the mouse EGF receptor effect of genetic background on mutant phenotype . Science. 269:1995;230.
15. Sibilia M., Wagner E.F. Strain dependent epithelial defects mice lacking the EGF receptor. Science. 269:1995;234.
16. Sands B.E., Podolsky D.K. The trefoil peptide family. Ann Rev Physiol. 58:1996;253.
17. Plaut A.G. Trefoil peptides in the defense of the gastrointestinal tract. N Engl J Med. 336:1997;506.
18. Playford R.J., Marchbank T., Goodlad R.A., Chinery R.A., Poulsom R., Hanby A.M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Nat Acad Sci USA. 93:1996;2137.
19. Mashimo H., Wu D.C., Podolsky D.K., Fishman M.C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:1996;262.
20. Massague J. The TGF-β family of growth and differentiation factors. Cell. 49:1987;437.
21. LaBrecque D.R. Hepatocyte growth factor - how do I know thee? Let me count the ways. Gastroenterology. 103:1992;1686.
22. Michalopoulos G.K., Zarnegar R. Hepatocyte growth factor. Hepatology. 15:1992;149.
23. Strain A.J. Hepatocyte growth factor another ubiquitous cytokine . J Endocrinol. 137:1993;1.
24. Kermorgant S., Walker F., Hormi K., Dresserier V., Lewin M.J., Lehy T. Developmental expression and functionality of hepatocyte growth factor and c-Met in human fetal digestive tissues. Gastroenterology. 112:1997;1635.
25. Uehara Y., Minowa O., Mori C., et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702.
26. Hoyt E.C., Lund P.K., Winesett D.E., et al. Effects of fasting, refeeding, and intraluminal triglyceride on proglucagon expression in jejunum and ileum. Diabetes. 45:1996;434.
27. Nightingale J.M., Kamm M.A., van der Sijp J.R., Ghatei M.A., Bloom S.R., Lennard-Jones J.E. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut. 39:1996;267.
28. Taylor R.G., Fuller P.J. Humoral regulation of intestinal adaptation. Baillieres Clin Endocrinol Metab. 8:1994;165.
29. Chaet M.S., Arya G., Ziegler M.M., Warner B.W. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg. 29:1994;1035.
30. Seydel A.S., Miller J.H., Sarac T.P., Ryan C.K., Sax H.C. Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor. Am J Surg. 172:1996;267.
31. Koldovsky O. Hormonally active peptides in human milk. Acta Paediatr. 402:(suppl):1994;89.
32. Odle J., Zijlstra R.T., Donovan S.M. Intestinal effects of milkborne growth factors in neonates of agricultural importance. J Animal Sci. 74:1996;2509.
33. Rao R.K. Biologically active peptides in the gastrointestinal lumen. Life Sci. 48:1991;1685.